Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000163433 | SCV000213979 | likely benign | Hereditary cancer-predisposing syndrome | 2015-09-02 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV000163433 | SCV000682512 | likely benign | Hereditary cancer-predisposing syndrome | 2017-05-29 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000700345 | SCV000829097 | likely benign | Ataxia-telangiectasia syndrome | 2024-12-24 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001651032 | SCV001868735 | likely benign | not provided | 2018-10-19 | criteria provided, single submitter | clinical testing | |
Institute for Clinical Genetics, |
RCV001651032 | SCV002010775 | uncertain significance | not provided | 2021-11-03 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV004589711 | SCV005083452 | benign | Familial cancer of breast | 2024-06-20 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |